Medtronic PLC (XSWX:MDT) Stock Price, Trades & News

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	0.33
Equity-to-Asset	0.53
Debt-to-Equity	0.57
Debt-to-EBITDA	2.85
Interest Coverage	9.56
Piotroski F-Score	7/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.74	Distress Grey Safe
Beneish M-Score	-2.58	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

6/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	6.4
	3-Year EBITDA Growth Rate	5.3
	3-Year EPS without NRI Growth Rate	1.5
	3-Year FCF Growth Rate	7
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	7.88
	Future 3-5Y Total Revenue Growth Rate Estimate	4.6

Momentum Rank

4/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	72.18
	9-Day RSI	68.21
	14-Day RSI	63.78
	3-1 Month Momentum %	-10.58
	6-1 Month Momentum %	-5.88
	12-1 Month Momentum %	7.53

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.13
	Quick Ratio	1.62
	Cash Ratio	0.79
	Days Inventory	170.88
	Days Sales Outstanding	64.58
	Days Payable	73.44

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	1.7
	Dividend Payout Ratio	0.13
	3-Year Dividend Growth Rate	1.4
	Forward Dividend Yield %	3.44
	5-Year Yield-on-Cost %	2.06
	3-Year Average Share Buyback Ratio	1.3
	Shareholder Yield %	2.91

Profitability Rank

7/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	65.02
	Operating Margin %	18.78
	Net Margin %	13.2
	EBITDA Margin %	26.98
	FCF Margin %	14.87
	OCF Margin %	20.11
	ROE %	9.88
	ROA %	5.24
	ROIC %	7.07
	3-Year ROIIC %	178.88
	ROC (Joel Greenblatt) %	52.15
	ROCE %	8.5
	Years of Profitability over Past 10-Year	10
	Moat Score	9
	Tariff Resilience Score	4

GF Value Rank

8/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	21.71
	Forward PE Ratio	14.16
	PE Ratio without NRI	14.64
	Shiller PE Ratio	22.38
	Price-to-Owner-Earnings	21.14
	PEG Ratio	2.76
	PS Ratio	2.87
	PB Ratio	2.1
	Price-to-Free-Cash-Flow	19.23
	Price-to-Operating-Cash-Flow	14.23
	EV-to-EBIT	17.95
	EV-to-Forward-EBIT	18.83
	EV-to-EBITDA	12.54
	EV-to-Forward-EBITDA	11.09
	EV-to-Revenue	3.38
	EV-to-Forward-Revenue	3.19
	EV-to-FCF	22.67
	Price-to-GF-Value	0.81
	Price-to-Projected-FCF	1.07
	Price-to-Median-PS-Value	0.73
	Earnings Yield (Greenblatt) %	5.57
	FCF Yield %	5.23
	Forward Rate of Return (Yacktman) %	9.07

GF Value™: CHF80.96

XSWX:MDT

Warning Signs

Warning! GuruFocus detected 3 Medium warning signs with MDT. Try a 7-Day Free Trial to check it out.

Medtronic PLC Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Medtronic PLC Stock Events

Financials Calendars

Event	Date	Price (CHF)
Second quarter earnings conference call for 2027	2026-11-18 07:00	In 144 days
Second quarter earnings results for 2027	2026-11-18 05:45	In 144 days
General meeting for 2026	2026-10-16 09:00	In 111 days
First quarter earnings conference call for 2027	2026-08-19 07:00	In 53 days
First quarter earnings results for 2027	2026-08-19 05:45	In 53 days
USD 0.720000 Cash Dividend	2026-06-26	65.98 (+0.00%)
Annual report for 2026	2026-06-18	64.14 (+0.00%)
Fourth quarter earnings conference call for 2026	2026-06-03 06:45	58.63 (+0.00%)
Fourth quarter earnings results for 2026	2026-06-03 05:45	58.63 (+0.00%)
USD 0.710000 Cash Dividend	2026-03-27	68.72 (+0.00%)

Show

Entries

Press Release

	Subject	Date
	Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care	2026-06-12
	Medtronic submits 510(k) filings to expand Hugo™ robotic-assisted surgery system into general and gynecologic specialties in the United States	2026-06-03
	Medtronic announces strategic investments to support future expansion of cardiac ablation portfolio as physician demand for Affera™ technologies broadens	2026-06-03
	Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years	2026-06-03
	Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain	2026-05-20
	Medtronic announces CE Mark for Stealth AXiS™ surgical system	2026-04-28
	Medtronic Launches Adaptive Deep Brain Stimulation System for Parkinson's Patients in India	2026-04-27
	Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues	2026-04-25
	During an Altaviva(TM) Implant, the Patient Talked About Lunch. That Was the Point	2026-04-21
	Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease	2026-04-20

10/Page

Articles on Medtronic PLC

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.